Lysosomal Storage Disease Flashcards
Gaucher: Genetics
Inheritance: Autosomal recessive
Gene: GBA
Deficient enzyme: Glucocerebrosidase
Excess metabolite: Glucocerebroside
Gaucher Disease: Type I
- Least severe
- Hepatosplenomegaly
- Thrombocytopenia
- Pulmonary hypertension
- Gaucher cells/bone crises
- Erlenmeyer flask deformity
- No CNS involvement
Gaucher Disease: Type II
- Most severe
- Bulbar and pyramidal signs
- Intellectual disability
- Convulsions
- Hypertonia
- Apnea
- No bone disease/crises
- Hepatosplenomegaly
- Thrombocytopenia
- Pulmonary hypertension
- Dermatologic abnormalities
- Lifespan 2-4 years
Gaucher Disease: Type III
- Intermediate phenotype
- Chronic neuropathic
- Progressive myoclonic epilepsy
- Oculomotor apraxia
- Hepatosplenomegaly
- Thrombocytopenia
- Pulmonary hypertension
- Gaucher cells/bone crises
- Erlenmeyer flask deformities
- Survival into teens and adulthood
Gaucher Disease: Treatment
Enzyme replacement therapy
oCerezyme, VPRIV, Elelyso
oMost effective for individuals with type I
oNot effective for individuals with type II (ERT cannot cross the blood-brain barrier)
oImproves some symptoms in individuals with type III
Substrate reduction therapy
oMiglustat, eliglustat
oFor individuals with type I, some type III who cannot do ERT due to allergic reaction, hypersensitivity, or poor venous access
Most common disease seen in the Ashkenazi Jewish population
Mucopolysaccharidoses (MPS): Genetics
Inheritance: Autosomal recessive, X-linked
Gene: Many, type-specific
Excess metabolite: Glycosaminoglycans (GAGs)
MPS I
Hurler Syndrome o Milder form called Hurler-Sheie •Developmental delay •Intellectual disability •Regression •Hepatosplenomegaly •Skeletal anomalies •Short stature •Cardiac anomalies •Corneal clouding (doesn’t affect vision) •Coarse facial features •Hearing loss
MPS II
Hunter Syndrome-->X-linked •Developmental delay •Intellectual disability •Regression •Skeletal anomalies •Short stature •Cardiac anomalies •CLEAR CORNEAS •Coarse facial features •Hearing loss
MPS III
San-Filippo Syndrome •Milder skeletal phenotype •Coarse facial features •Progressive sleep and behavioral problems •NO CARDIAC ANOAMLIES •CLEAR CORNEAS
MPS IV
Morquio Syndrome •Severe skeletal phenotype oShort-trunked dwarfism •NORMAL INTELLECT •Chest deformities •Cardiac anomalies •Bone malformation •Macrocephaly
MPS VI
Maroteaux-Lamy syndrome •Coarse facial features •Skeletal anomalies •Short stature •Cardiac anomalies •Corneal clouding •NORMAL INTELLECT
MPS VII
Sly syndrome •Developmental delay •Regresison •Cardiac anomalies •Hepatosplenomegaly •Coarse facial features •Recurrent ENT problems
MPS Treatment:
ERT is available and may treat visceral symptoms, but cannot treat cognitive symptoms in types I, II, III, and VII because it cannot cross the BBB
Niemann-Pick Disease: Genetics
Inheritance: Autosomal recessive
Gene: SMPD1, NPC1
Deficient enzyme: Acid sphingomyelinase
Excess metabolite: Sphingomyelin
Niemann-Pick Disease, Type A
Type A: •Hepatosplenomegaly •Failure to thrive •Progressive nervous system deterioration •Profound brain damage •Development stops at 12 months and regresses •Pulmonary insufficiency •Recurrent lung infections •Cherry-red spot on ophthalmologic exam •Death by age 3